yeah thats not good - so do you think that this is to be a recurring issue with any other generics in the pipeline? because if so then gosh going to be an almighty cash drain and all i can see are multiple CR's - would love to know what KPI's are for their bonuses if SP not one of them - do they get bonus based on finishing a product, during the "creation' of the product or FDA approval because thats when it is finally cleared as being safe for sale?. i wager they get it on all three!!!)
ACR Price at posting:
7.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)